NCT00066404View on ClinicalTrials.gov

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Cancer
Interventions
BIOLOGICAL

recombinant adenovirus-hIFN-beta

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT00066404 - Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions | Biotech Hunter | Biotech Hunter